Annual Shareholders Equity
-$2.90 M
-$40.64 M-107.69%
31 December 2023
Summary:
Aptose Biosciences annual stockholders equity is currently -$2.90 million, with the most recent change of -$40.64 million (-107.69%) on 31 December 2023. During the last 3 years, it has fallen by -$121.82 million (-102.44%). APTO annual shareholders equity is now -102.44% below its all-time high of $118.92 million, reached on 31 December 2020.APTO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$9.13 M
-$6.96 M-319.76%
30 September 2024
Summary:
Aptose Biosciences quarterly stockholders equity is currently -$9.13 million, with the most recent change of -$6.96 million (-319.76%) on 30 September 2024. Over the past year, it has dropped by -$16.91 million (-217.46%). APTO quarterly shareholders equity is now -107.07% below its all-time high of $129.16 million, reached on 30 September 2020.APTO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -107.7% | -217.5% |
3 y3 years | -102.4% | -110.3% |
5 y5 years | -120.6% | -133.3% |
APTO Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -102.4% | at low | -110.3% | at low |
5 y | 5 years | -102.4% | at low | -107.1% | at low |
alltime | all time | -102.4% | +62.1% | -107.1% | at low |
Aptose Biosciences Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$9.13 M(+319.8%) |
June 2024 | - | -$2.18 M(-1688.3%) |
Mar 2024 | - | $137.00 K(-104.7%) |
Dec 2023 | -$2.90 M(-107.7%) | -$2.90 M(-137.3%) |
Sept 2023 | - | $7.78 M(-43.6%) |
June 2023 | - | $13.79 M(-47.0%) |
Mar 2023 | - | $25.99 M(-31.1%) |
Dec 2022 | $37.74 M(-49.2%) | $37.74 M(-19.4%) |
Sept 2022 | - | $46.81 M(-15.6%) |
June 2022 | - | $55.49 M(-15.0%) |
Mar 2022 | - | $65.28 M(-12.1%) |
Dec 2021 | $74.24 M(-37.6%) | $74.24 M(-16.3%) |
Sept 2021 | - | $88.68 M(-9.7%) |
June 2021 | - | $98.19 M(-10.3%) |
Mar 2021 | - | $109.41 M(-8.0%) |
Dec 2020 | $118.92 M(+26.6%) | $118.92 M(-7.9%) |
Sept 2020 | - | $129.16 M(+63.0%) |
June 2020 | - | $79.22 M(-9.2%) |
Mar 2020 | - | $87.24 M(-7.1%) |
Dec 2019 | $93.93 M(+567.0%) | $93.93 M(+242.4%) |
Sept 2019 | - | $27.43 M(-18.7%) |
June 2019 | - | $33.76 M(+118.9%) |
Mar 2019 | - | $15.42 M(+9.5%) |
Dec 2018 | $14.08 M(+38.0%) | $14.08 M(+1.1%) |
Sept 2018 | - | $13.93 M(-17.5%) |
June 2018 | - | $16.89 M(+16.7%) |
Mar 2018 | - | $14.47 M(+41.8%) |
Dec 2017 | $10.20 M(+39.2%) | $10.20 M(+3.3%) |
Sept 2017 | - | $9.88 M(-4.0%) |
June 2017 | - | $10.29 M(+32.7%) |
Mar 2017 | - | $7.75 M(+5.8%) |
Dec 2016 | $7.33 M(-46.3%) | $7.33 M(+6.2%) |
Sept 2016 | - | $6.90 M(-23.9%) |
June 2016 | - | $9.07 M(-18.0%) |
Mar 2016 | - | $11.06 M(-19.0%) |
Dec 2015 | $13.65 M(-45.9%) | $13.65 M(-19.0%) |
Sept 2015 | - | $16.86 M(-16.0%) |
June 2015 | - | $20.07 M(-7.0%) |
Mar 2015 | - | $21.59 M(-24.6%) |
Dec 2014 | $25.22 M(-3.8%) | - |
Sept 2014 | - | $28.61 M(+9.2%) |
May 2014 | $26.21 M(-3558.6%) | $26.21 M(+620.6%) |
Feb 2014 | - | $3.64 M(-343.8%) |
Nov 2013 | - | -$1.49 M(-8.5%) |
Aug 2013 | - | -$1.63 M(+115.2%) |
May 2013 | -$757.80 K(-61.5%) | -$757.80 K(-293.5%) |
Feb 2013 | - | $391.70 K(-76.2%) |
Nov 2012 | - | $1.64 M(-47.5%) |
Aug 2012 | - | $3.13 M(-259.0%) |
May 2012 | -$1.97 M(-904.3%) | -$1.97 M(+82.7%) |
Feb 2012 | - | -$1.08 M(+1534.6%) |
Nov 2011 | - | -$65.90 K(-106.0%) |
Aug 2011 | - | $1.09 M(+345.4%) |
May 2011 | $244.70 K | $244.70 K(-86.1%) |
Feb 2011 | - | $1.76 M(+30.5%) |
Date | Annual | Quarterly |
---|---|---|
Nov 2010 | - | $1.35 M(-186.3%) |
Aug 2010 | - | -$1.56 M(+204.4%) |
May 2010 | -$513.70 K(-93.3%) | -$513.70 K(-146.5%) |
Feb 2010 | - | $1.10 M(-51.5%) |
Nov 2009 | - | $2.28 M(+63.2%) |
Aug 2009 | - | $1.40 M(-118.2%) |
May 2009 | -$7.66 M(+97.8%) | -$7.66 M(+45.5%) |
Feb 2009 | - | -$5.27 M(+45.7%) |
Nov 2008 | - | -$3.61 M(+50.6%) |
Aug 2008 | - | -$2.40 M(-38.1%) |
May 2008 | -$3.87 M(-644.7%) | -$3.87 M(+510.1%) |
Feb 2008 | - | -$635.00 K(-123.1%) |
Nov 2007 | - | $2.75 M(-43.0%) |
Aug 2007 | - | $4.83 M(+578.6%) |
May 2007 | $711.20 K(-130.6%) | $711.20 K(-63.9%) |
Feb 2007 | - | $1.97 M(-43.9%) |
Nov 2006 | - | $3.51 M(-42.2%) |
Aug 2006 | - | $6.07 M(-361.4%) |
May 2006 | -$2.32 M(-122.0%) | -$2.32 M(-4327.9%) |
Feb 2006 | - | $54.90 K(-98.2%) |
Nov 2005 | - | $3.03 M(-55.1%) |
Aug 2005 | - | $6.75 M(-36.2%) |
May 2005 | $10.57 M(-49.6%) | $10.57 M(-17.1%) |
Feb 2005 | - | $12.76 M(-20.0%) |
Nov 2004 | - | $15.95 M(-7.2%) |
Aug 2004 | - | $17.19 M(-18.1%) |
May 2004 | $20.99 M(-0.3%) | $20.99 M(-23.3%) |
Feb 2004 | - | $27.38 M(-20.4%) |
Nov 2003 | - | $34.37 M(-6.0%) |
Aug 2003 | - | $36.55 M(+73.6%) |
May 2003 | $21.05 M(-27.1%) | $21.05 M(-4.2%) |
Feb 2003 | - | $21.97 M(-5.1%) |
Nov 2002 | - | $23.15 M(-10.1%) |
Aug 2002 | - | $25.74 M(-10.9%) |
May 2002 | $28.89 M(-20.6%) | $28.89 M(-3.2%) |
Feb 2002 | - | $29.85 M(-6.3%) |
Nov 2001 | - | $31.84 M(-6.9%) |
Aug 2001 | - | $34.20 M(-6.0%) |
May 2001 | $36.38 M(-20.7%) | $36.38 M(-8.9%) |
Feb 2001 | - | $39.95 M(-2.6%) |
Nov 2000 | - | $41.02 M(-9.1%) |
Aug 2000 | - | $45.13 M(-1.7%) |
May 2000 | $45.89 M(+3461.0%) | $45.89 M(+131.2%) |
Feb 2000 | - | $19.85 M(+26.0%) |
Nov 1999 | - | $15.76 M(+1862.3%) |
Aug 1999 | - | $802.90 K(-37.7%) |
May 1999 | $1.29 M(-60.9%) | $1.29 M(-39.3%) |
Feb 1999 | - | $2.12 M(+12.4%) |
Nov 1998 | - | $1.89 M(-21.5%) |
Aug 1998 | - | $2.40 M(-27.0%) |
May 1998 | $3.30 M(-52.2%) | $3.30 M(-13.2%) |
Feb 1998 | - | $3.79 M(-21.7%) |
Nov 1997 | - | $4.85 M(-20.8%) |
Aug 1997 | - | $6.12 M |
May 1997 | $6.89 M | - |
FAQ
- What is Aptose Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Aptose Biosciences?
- What is Aptose Biosciences annual shareholders equity year-on-year change?
- What is Aptose Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aptose Biosciences?
- What is Aptose Biosciences quarterly shareholders equity year-on-year change?
What is Aptose Biosciences annual stockholders equity?
The current annual shareholders equity of APTO is -$2.90 M
What is the all time high annual shareholders equity for Aptose Biosciences?
Aptose Biosciences all-time high annual stockholders equity is $118.92 M
What is Aptose Biosciences annual shareholders equity year-on-year change?
Over the past year, APTO annual stockholders equity has changed by -$40.64 M (-107.69%)
What is Aptose Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of APTO is -$9.13 M
What is the all time high quarterly shareholders equity for Aptose Biosciences?
Aptose Biosciences all-time high quarterly stockholders equity is $129.16 M
What is Aptose Biosciences quarterly shareholders equity year-on-year change?
Over the past year, APTO quarterly stockholders equity has changed by -$16.91 M (-217.46%)